Late toxicity following craniospinal radiation for early-stage medulloblastoma

References

• Fossati P, Ricardi U, Orecchia R. Pediatric medulloblastoma: Toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 2009;35:79–96.
   PubMed Web of Science ®Google Scholar
• Gajjar A, Packer RJ, Foreman NK, Cohen K, Haas-Kogan D, Merchant TE, et al. Children’s Oncology Group’s 2013 blueprint for research: Central nervous system tumors. Pediatr Blood Cancer 2013;60:1022–6.
   PubMed Web of Science ®Google Scholar
• Brasme JF, Grill J, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, et al. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PloS One 2012;7:e33415.
   PubMed Web of Science ®Google Scholar
• Polkinghorn WR, Dunkel IJ, Souweidane MM, Khakoo Y, Lyden DC, Gilheeney SW, et al. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Int J Radiat Oncol Biol Phys 2011;81:e15–20.
   Web of Science ®Google Scholar
• Punyko JA, Mertens AC, Gurney JG, Yasui Y, Donaldson SS, Rodeberg DA, et al. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study. Pediatr Blood Cancer 2005;44:643–53.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Jain N, Liu W, Merchant TE, Stovall M, Srivastava DK, et al. Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neurooncology 2010;12:1173–86.
   PubMed Web of Science ®Google Scholar
• Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005;23:5511–9.
   PubMed Web of Science ®Google Scholar
• Duff D. Ageism, elitism, and anti-intellectualism in nursing. Axone 2005;26:4–5.
   PubMedGoogle Scholar
• Paulino AC. Hypothyroidism in children with medulloblastoma: A comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002;53:543–7.
   PubMed Web of Science ®Google Scholar
• Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, et al. Necrosis after craniospinal irradiation: Results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 2012;83:e655–60.
   PubMed Web of Science ®Google Scholar
• Strodtbeck K, Sloan A, Rogers L, Fisher PG, Stearns D, Campbell L, et al. Risk of subsequent cancer following a primary CNS tumor. J Neuro-oncol 2013;112:285–95.
   PubMed Web of Science ®Google Scholar
• Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 2001;23:431–6.
   PubMed Web of Science ®Google Scholar
• Goldstein AM, Yuen J, Tucker MA. Second cancers after medulloblastoma: Population-based results from the United States and Sweden. Cancer Cause Control 1997;8:865–71.
   PubMed Web of Science ®Google Scholar
• Hamasaki K, Nakamura H, Ueda Y, Makino K, Kuratsu J. Radiation-induced glioblastoma occurring 35 years after radiation therapy for medulloblastoma: Case report. Brain Tumor Pathol 2010;27:39–43.
   PubMed Web of Science ®Google Scholar
• Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2006;24:5277–82.
   PubMed Web of Science ®Google Scholar
• Benson PJ, Sung JH. Cerebral aneurysms following radiotherapy for medulloblastoma. J Neurosurg 1989;70:545–50.
   PubMed Web of Science ®Google Scholar
• Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010;28:1308–15.
   PubMed Web of Science ®Google Scholar
• Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol 2013;58:807–23.
   PubMed Web of Science ®Google Scholar
• Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D’Amelio AM, Jr., et al. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 2012;7:116.
   PubMed Web of Science ®Google Scholar
• Moeller BJ, Chintagumpala M, Philip JJ, Grosshans DR, McAleer MF, Woo SY, et al. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol 2011;6:58.
   PubMed Web of Science ®Google Scholar
• Kahalley L, Okcu MF, Ris MD, Grosshans D, Paulino A, Chintagumpala M, et al. IQ change within three years of radiation therapy in pediatric brain tumor patients treated with proton beam radiation therapy versus photon radiation therapy. J Clin Oncol 2013;31(Suppl; abstr 10009).
   Google Scholar
• Yock TI, Yeap BY, Pulsifer MB, Ebb D, MacDonald SM, Marcus KC, et al. Results from a prospective trial of proton radiotherapy for medulloblastoma: Clinical outcomes including hearing and neurocognitive. Int J Radiat Oncol Biol Phys 2011;81:S113.
   Web of Science ®Google Scholar
• Moeller BJ, Chintagumpala M, Philip JJ, Woo SY, Wolff JE, Mahajan A. Proton radiotherapy for pediatric medulloblastoma: Improved early ototoxicity. Int J Radiat Oncol Biol Phys 2010;78:S18.
   Web of Science ®Google Scholar
• Zhang R, Howell RM, Homann K, Giebeler A, Taddei PJ, Mahajan A, et al. Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol 2013;8:184.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Vogelius IR, Maraldo MV, Munck af Rosenschold P, Aznar MC, Kiil-Berthelsen A, et al. Life years lost – comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer 2012;118:5432–40.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Munck Af Rosenschold P, Aznar MC, Kiil- Berthelsen A, Vogelius IR, Nilsson P, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011;50:806–16.
   PubMed Web of Science ®Google Scholar